Liquid biopsy-based minimal residual disease monitoring for early risk stratification and decision-making in advanced non-small cell lung cancer

Alessandra I.G. Buma
alessandra.buma@radboudumc.nl

Request Access

Dataset ID	Description	Technology	Samples
EGAD50000002230	Liquid biopsies generated for minimal residual disease monitoring of non-small cell lung cancer. Ultra deep targeted sequencing of lung cancer related genes with UMIs. This dataset contains the dedication cohort	Illumina NovaSeq 6000	505
EGAD50000002231	Liquid biopsies generated for minimal residual disease monitoring of advanced non-small cell lung cancer. Ultra deep targeted sequencing of lung cancer specific genes, with UMIs. This dataset consists of the biobank cohort	Illumina NovaSeq 6000	152